Somru BioScience Inc.

Somru BioScience is a forward-thinking contract research organization (CRO) redefining drug development with technology-driven and AI-powered solutions. At the forefront of innovation, Somru BioScience combines advanced science and cutting-edge platforms to support pharmaceutical and biotech partners across all phases of development.

Central to its offerings is Aegyris, an AI-driven platform designed to streamline and optimize data analysis, accelerating decision-making in drug development. Complementing this is Amplatto, an ultrasensitive analytical platform enabling precise quantification and detection of therapeutic molecules, and Intelli.b, a revolutionary biologics fingerprinting solution that delivers unparalleled insights into molecular characteristics, supporting biosimilar and biologics development.

Somru BioScience also provides an extensive range of services, including pharmacokinetics (PK), immunogenicity, biomarker analysis, and cell-based assays. Its expertise extends to assay development, validation, and sample analysis under non-GLP, GLP, and GCP standards.

With a team of highly skilled scientists and quality assurance professionals, Somru BioScience is committed to scientific excellence, data integrity, and regulatory compliance. By leveraging AI and advanced analytical platforms, Somru BioScience empowers its partners with transformative tools and insights, ensuring faster, more reliable outcomes in diverse therapeutic areas.